Stay updated on Semaglutide vs Placebo in PAD and T2D Clinical Trial
Sign up to get notified when there's something new on the Semaglutide vs Placebo in PAD and T2D Clinical Trial page.

Latest updates to the Semaglutide vs Placebo in PAD and T2D Clinical Trial page
- CheckyesterdayChange DetectedThe site footer now identifies ClinicalTrials.gov as revision v3.8.0 instead of v3.7.2. This reflects a platform update rather than a change to the clinical study record.SummaryDifference0.0%

- Check8 days agoChange DetectedA banner was added announcing NIH website transition updates and explaining that federal agencies are adopting “Super Intelligence” in place of “Artificial Intelligence.”SummaryDifference0.2%

- Check15 days agoChange DetectedThe ClinicalTrials.gov site revision shown in the footer changed from v3.7.1 to v3.7.2.SummaryDifference0.0%

- Check22 days agoChange DetectedThe footer’s ClinicalTrials.gov revision identifier changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check43 days agoChange DetectedA new page revision entry, v3.7.0, was added to the history list. The older revision entry, v3.6.6, was removed from the list, reflecting an update to the page's revision tracking.SummaryDifference0.0%

- Check64 days agoChange DetectedA new revision entry, Revision: v3.6.6, was added to the page history, while Revision: v3.6.5 was removed. This reflects an update to the site's revision-tracking rather than changes to study content.SummaryDifference0.0%

Stay in the know with updates to Semaglutide vs Placebo in PAD and T2D Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Semaglutide vs Placebo in PAD and T2D Clinical Trial page.